Loading...
180 Life Sciences Corp.
ATNF•NASDAQ
Healthcare
Biotechnology
$2.21
$-0.60(-21.35%)
180 Life Sciences Corp. (ATNF) Financial Performance & Statements
Review 180 Life Sciences Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
53.07%
↑ 53.07%
Net Income Growth
69.06%
↑ 69.06%
Operating Cash Flow Growth
86.44%
↑ 86.44%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-147.34%
↓ 147.34%
ROIC
-85.68%
↓ 85.68%
180 Life Sciences Corp. (ATNF) Financial Statements
Explore quarterly and annual reports for 180 Life Sciences Corp. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $23981.00 | $23576.00 |
| Gross Profit | $0.00 | $0.00 | -$23981.00 | -$23576.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $408836.00 | $402715.00 | $621988.00 | $535728.00 |
| SG&A Expenses | $997594.00 | $576378.00 | $1.22M | $1.53M |
| Operating Expenses | $1.41M | $979093.00 | $1.85M | $2.07M |
| Total Costs & Expenses | $1.41M | $979093.00 | $1.85M | $2.09M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $9198.00 | $13633.00 | $11360.00 | $16449.00 |
| Depreciation & Amortization | -$3131.00 | $13851.00 | $23981.00 | $23576.00 |
| EBITDA | -$4.56M | -$809239.00 | -$1.82M | -$1.03M |
| EBITDA Ratio | ||||
| Operating Income | -$1.41M | -$979093.00 | -$1.85M | -$2.09M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$3.16M | $142373.00 | $1.86M | $1.02M |
| Income Before Tax | -$4.57M | -$836720.00 | $11781.00 | -$1.07M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | -$296024.00 | $0.00 | $0.00 | $4.00 |
| Net Income | -$4.27M | -$836720.00 | $11781.00 | -$1.07M |
| Net Income Ratio | ||||
| EPS | -$0.85 | -$0.85 | $0.01 | -$1.68 |
| Diluted EPS | -$0.85 | -$0.85 | $0.01 | -$1.68 |
| Weighted Avg Shares Outstanding | $980641.00 | $980641.00 | $919141.00 | $638339.00 |
| Weighted Avg Shares Outstanding (Diluted) | $980641.00 | $980641.00 | $919141.00 | $638339.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan